Protagonist Therapeutics (NASDAQ:PTGX) Price Target Raised to $76.00 at Truist Financial
Protagonist Therapeutics (NASDAQ:PTGX – Free Report) had its price objective hoisted by Truist Financial from $60.00 to $76.00 in a research note released on Tuesday morning,Benzinga reports. The firm currently has a buy rating on the stock. Other equities analysts have also recently issued reports about the company. HC Wainwright reiterated a “buy” rating and […]
Protagonist Therapeutics (NASDAQ:PTGX – Free Report) had its price objective hoisted by Truist Financial from $60.00 to $76.00 in a research note released on Tuesday morning,Benzinga reports. The firm currently has a buy rating on the stock. Other equities analysts have also recently issued reports about the company. HC Wainwright reiterated a “buy” rating and […]
